The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bour, H.
Right arrow Articles by MacDonald, H. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bour, H.
Right arrow Articles by MacDonald, H. R.
Right arrowPubmed/NCBI databases
*Substance via MeSH
The Journal of Immunology, 1998, 160: 5522-5529.
Copyright © 1998 by The American Association of Immunologists

Differential Requirement for CD4 Help in the Development of an Antigen-Specific CD8+ T Cell Response Depending on the Route of Immunization1

Hélène Bour*, Clotilde Horvath*, Christophe Lurquin{dagger}, Jean-Charles Cerottini* and H. Robson MacDonald2,*

* Ludwig Institute for Cancer Research, Lausanne Branch, University of Lausanne, Epalinges, Switzerland; and {dagger} Ludwig Institute for Cancer Research, Brussels Branch, Brussels, Belgium

Previous studies in our laboratory have shown that DBA/2 mice injected i.p. with syngeneic P815 tumor cells transfected with the HLA-CW3 gene (P815-CW3) showed a dramatic expansion of activated CD8+CD62L- T cells expressing exclusively the Vß10 segment. We have used this model to study the regulatory mechanisms involved in the development of the CW3-specific CD8+ response, with respect to different routes of immunization. Whereas both intradermal (i.d.) and i.p. immunization of DBA/2 mice with P815-CW3 cells led to a strong expansion of CD8+CD62L-Vß10+ cells, only the i.d. route allowed this expansion after immunization with P815 cells transfected with a minigene coding for the antigenic epitope CW3 170–179 (P815 miniCW3). Furthermore, depletion of CD4+ T cells in vivo completely abolished the specific response of CD8+CD62L-Vß10+ cells and prevented the rejection of P815-CW3 tumor cells injected i.p, whereas it did not affect CD8+CD62L-Vß10+ cell expansion after i.d. immunization with either P815-CW3 or P815 miniCW3. Finally, the CW3-specific CD8+ memory response was identical whether or not CD4+ T cells were depleted during the primary response. Collectively, these results suggest that the CD8+ T cell response to P815-CW3 tumor cells injected i.p. is strictly dependent upon recognition of a helper epitope by CD4+ T cells, whereas no such requirement is observed for i.d. injection.




This article has been cited by other articles:


Home page
Cancer Res.Home page
A. Saha, S. K. Chatterjee, K. A. Foon, E. Celis, and M. Bhattacharya-Chatterjee
Therapy of Established Tumors in a Novel Murine Model Transgenic for Human Carcinoembryonic Antigen and HLA-A2 with a Combination of Anti-idiotype Vaccine and CTL Peptides of Carcinoembryonic Antigen
Cancer Res., March 15, 2007; 67(6): 2881 - 2892.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
Y. Peng, H. Shao, Y. Ke, P. Zhang, J. Xiang, H. J. Kaplan, and D. Sun
In Vitro Activation of CD8 Interphotoreceptor Retinoid-Binding Protein-Specific T Cells Requires not only Antigenic Stimulation but also Exogenous Growth Factors.
J. Immunol., April 15, 2006; 176(8): 5006 - 5014.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
H.-M. Hu, H. Winter, W. J. Urba, and B. A. Fox
Divergent Roles for CD4+ T Cells in the Priming and Effector/Memory Phases of Adoptive Immunotherapy
J. Immunol., October 15, 2000; 165(8): 4246 - 4253.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
P. R. Walker, T. Calzascia, V. Schnuriger, N. Scamuffa, P. Saas, N. de Tribolet, and P.-Y. Dietrich
The Brain Parenchyma Is Permissive for Full Antitumor CTL Effector Function, Even in the Absence of CD4 T Cells
J. Immunol., September 15, 2000; 165(6): 3128 - 3135.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. De Creus, K. Van Beneden, T. Taghon, F. Stolz, V. Debacker, J. Plum, and G. Leclercq
Langerhans Cells That Have Matured In Vivo in the Absence of T Cells Are Fully Capable of Inducing a Helper CD4 as Well as a Cytotoxic CD8 Response
J. Immunol., July 15, 2000; 165(2): 645 - 653.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
P. Bousso, F. Lemaitre, D. Laouini, J. Kanellopoulos, and P. Kourilsky
The peripheral CD8 T cell repertoire is largely independent of the presence of intestinal flora
Int. Immunol., April 1, 2000; 12(4): 425 - 430.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. Wild, M. J. Grusby, R. Schirmbeck, and J. Reimann
Priming MHC-I-Restricted Cytotoxic T Lymphocyte Responses to Exogenous Hepatitis B Surface Antigen Is CD4+ T Cell Dependent
J. Immunol., August 15, 1999; 163(4): 1880 - 1887.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
G. Perrin, V. Schnuriger, A.-L. Quiquerez, P. Saas, C. Pannetier, N. de Tribolet, J.-M. Tiercy, J.-P. Aubry, P.-Y. Dietrich, and P. R. Walker
Astrocytoma infiltrating lymphocytes include major T cell clonal expansions confined to the CD8 subset
Int. Immunol., August 1, 1999; 11(8): 1337 - 1350.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
H. Bour, O. Michielin, P. Bousso, J.-C. Cerottini, and H. R. MacDonald
Dramatic Influence of V{beta} Gene Polymorphism on an Antigen-Specific CD8+ T Cell Response In Vivo
J. Immunol., April 15, 1999; 162(8): 4647 - 4656.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1998 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1998 by The American Association of Immunologists, Inc. All rights reserved.